Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. - Kolterman,O.G.; Buse,J.B.; Fineman,M.S.; Gaines,E.; Heintz,S.; Bicsak,T.A.; Taylor,K.; Kim,D.; Aisporna,M.; Wang,Y.; Baron,A.D. (J Clin Endocrinol Metab, 2003)